Drug intelligence / Profile preview

Cerasorb M

Development stage
Unknown
Lead developer
Curasan
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
Administration
Surgical Implantation
01

Overview

Cerasorb M is a synthetic, fully resorbable bone graft material composed of pure-phase beta-tricalcium phosphate (β-TCP) with greater than 99% phase purity. It is designed to mimic the structure and porosity of human bone, featuring interconnected micro-, meso-, and macropores (5–500 μm) that facilitate osteoconduction, angiogenesis, and rapid cellular infiltration. The granules are polygonal and irregularly shaped to enhance interlocking within defect sites. Cerasorb M serves as a scaffold for new bone growth by supporting the migration of osteogenic cells and vascular structures into the defect area. As it is resorbed at a rate matching new bone formation, it enables complete remodeling into vital bone tissue without leaving fibrous residues or biologic contaminants. Primary indications include augmentation or reconstructive treatment of the alveolar ridge, filling infrabony periodontal defects, post-extraction socket preservation, sinus floor elevation in dental implantology, repair of non-infected bone defects in oral/maxillofacial surgery and orthopedics (including intervertebral grafts), peri-implant defects, horizontal/vertical augmentation procedures, cystectomy/apicoectomy voids filling, general grafting procedures in dentistry/orthopedics/plastic reconstruction[1][2][4][5][6].

Brand names
Cerasorb M
Other names
Tricalcium phosphate

Beyond the preview

Go deeper on Cerasorb M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerasorb M.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call